摘要
在小细胞肺癌发病的早中期,手术切除是达到治愈目的的首选方案,但术后的患者较易发生后遗症,发生最多的是顽固性咳嗽。目前研究认为纵隔淋巴结清扫、术后气管生理改变是肺癌术后顽固性咳嗽的重要因素。现代医学采取改变麻醉部位、填充脂肪等措施预防术后顽固性咳嗽发生,而术后口服药物的研究则相对薄弱。传统医学以辨证施治为特点,具有多靶点的优势,运用西药抗治疗同时,联合中药治疗效果显著,是对西医治疗的有益补充。
In the early and middle stages of small cell lung cancer,surgical resection is the first choice to achieve cure,but postoperative patients are prone to sequelae,most of which is intractable cough.Current studies suggest that mediastinal lymph node dissection and postoperative physiological changes of trachea are important factors for intractable cough after lung cancer surgery.Modern medicine takes measures such as changing anesthesia site and filling fat to prevent intractable cough after surgery,but the research on oral drugs after surgery is relatively weak.Traditional medicine is characterized by syndrome differentiation and treatment,and has the advantage of multiple targets.The combination of western medicine and traditional Chinese medicine has a remarkable effect on anti-therapy,which is a beneficial supplement to western medicine.
作者
白海春
杨建雅
李素云
姚富科
BAI Haichun;YANG Jianya;LI Suyun;YAO Fuke(Henan University of Chinese Medicine,Zhengzhou 450046,Henan,China;The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450000,Henan,China)
出处
《实用中医内科杂志》
2022年第12期33-36,共4页
Journal of Practical Traditional Chinese Internal Medicine
基金
中医药传承与创新“百千万”人才工程(岐黄工程)项目岐黄学者项目(国中医药人教函〔2018〕284号)
中原千人计划-中原学者项目(202101510002)。
关键词
肺癌术后
顽固性咳嗽
中西医治疗
研究进展
postoperative lung cancer
refractory cough
integrated traditional Chinese and Western medicine therapy
research progress
